Emmessar Biotech's AGM Approves Financials and Director Re-appointment

Emmessar Biotech & Nutrition Ltd held its 34th Annual General Meeting (AGM) on September 29, 2026. The company announced the adoption of Audited Financial Statements for the fiscal year ended March 31, 2026. Additionally, shareholders approved the re-appointment of Mr. Jeyavel Balaiah Nadar as Director and the re-appointment of Mr. Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director for a further period of 5 years. Both resolutions were passed as Ordinary Resolutions, with strong support from promoters and a mixed response from public non-institutions on the financial statement adoption.